Ayaz Aghayev

Dr. Ayaz Aghayev


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in Radiology
Verified
Journal Article
Closed access
AFAlessandro Furlan
Alessandro Furlan
AAAyaz Aghayev
Ayaz Aghayev
CCChung-Chou H. Chang
Chung-Chou H. Chang
APAmol Patil
Amol Patil
KJKyung Nyeo Jeon
Kyung Nyeo Jeon
KBKyongtae T. Bae
Kyongtae T. Bae
In patients with acute pulmonary embolism, right heart dilatation was associated with higher risk of short-term mortality along with history of congestive heart failure and cancer. PurposeTo assess the correlation between volumetric measurements of clot, semiquantitative clot burden indexes, and signs of right heart dysfunction at computed tomographic (CT) pulmonary angiograp...

1 January 2019 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
CGChristoph Gräni
Christoph Gräni
CEChristian Eichhorn
Christian Eichhorn
LBLoïc Bière
Loïc Bière
KKKyoichi Kaneko
Kyoichi Kaneko
VMVenkatesh L. Murthy
Venkatesh L. Murthy
RKRaymond Y. Kwong
Raymond Y. Kwong
Although the presence of late gadolinium enhancement (LGE) using cardiovascular magnetic resonance imaging (CMR) is a significant discriminator of events in patients with suspected myocarditis, no data are available on the optimal LGE quantification method. Six hundred seventy consecutive patients (48 ± 16 years, 59% male) with suspected myocarditis were enrolled between 2002 and 2015. We performed LGE quantitation using seven different signal intensity thresholding methods based either on 2, 3, 4, 5, 6, 7 standard deviations (SD) above remote myocardium or full width at half maximum (FWHM). In addition, a LGE visual presence score (LGE-VPS) (LGE present/absent in each segment) was assessed. For each of these methods, the strength of association of LGE results with major adverse cardiac events (MACE) was determined. Inter-and intra-rater variability using intraclass-correlation coefficient (ICC) was performed for all methods. Ninety-eight (15%) patients experienced a MACE at a medium follow-up of 4.7 years. LGE quantification by FWHM, 2- and 3-SD demonstrated univariable association with MACE (hazard ratio [HR] 1.05, 95% confidence interval [CI]:1.02–1.08, p = 0.001; HR 1.02, 95%CI:1.00–1.04; p = 0.001; HR 1.02, 95%CI: 1.00–1.05, p = 0.035, respectively), whereas 4-SD through 7-SD methods did not reach significant association. LGE-VPS also demonstrated association with MACE (HR 1.09, 95%CI: 1.04–1.15, p < 0.001). In the multivariable model, FWHM, 2-SD methods, and LGE-VPS each demonstrated significant association with MACE adjusted to age, sex, BMI and LVEF (adjusted HR of 1.04, 1.02, and 1.07; p = 0.009, p = 0.035; and p = 0.005, respectively). In these, FWHM and LGE-VPS had the highest degrees of inter and intra-rater reproducibility based on their high ICC values. FWHM is the optimal semi-automated quantification method in risk-stratifying patients with suspected myocarditis, demonstrating the strongest association with MACE and the highest technical consistency. Visual LGE scoring is a reliable alternative method and is associated with a comparable association with MACE and reproducibility in these patients. NCT03470571 . Registered 13th March 2018. Retrospectively registered.

8 January 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
NMNegareh Mousavi
Negareh Mousavi
MCMichael K. Cheezum
Michael K. Cheezum
AAAyaz Aghayev
Ayaz Aghayev
RPRobert Padera
Robert Padera
TVTomas Vita
Tomas Vita
RBRon Blankstein
Ron Blankstein
Background: Cardiac magnetic resonance imaging ( CMR ) provides useful information for characterizing cardiac masses, but there are limited data on whether CMR can accurately distinguish benign from malignant lesions. We aimed to describe the distribution and imaging characteristics of cardiac masses identified by CMR and to determine the diagnostic accuracy of CMR for distinguishing benign from malignant tumors. Methods and Results: We examined consecutive patients referred for CMR between May 2008 and August 2013 to identify those with a cardiac mass. In patients for whom there was histological correlation, 2 investigators blinded to all data analyzed the CMR images to categorize the mass as benign or malignant. For benign masses, readers were also asked to specify the most likely diagnosis. Benign masses were defined as benign neoplastic or non‐neoplastic. Malignant masses were defined as primary cardiac or metastatic. Of 8069 patients (mean age: 58±16 years; 55% female) undergoing CMR , 145 (1.8%) had a cardiac mass. In most cases (142, 98%), there was a known cardiac mass before the CMR study. Among 145 patients with a cardiac mass, 93 (64%) had a known history of malignancy. Among 53 cases that had histological correlation, 25 (47%) were benign, 26 (49%) were metastatic, and 2 (4%) were malignant primary cardiac masses. Blinded readers correctly diagnosed 89% to 94% of the cases as benign versus malignant, with a 95% agreement rate (κ=0.83). Conclusions: Although C MR can be highly effective in distinguishing benign from malignant lesions, pathology remains the gold standard in accurately determining the type of mass.

1 November 2015 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
YAYazan Z. Alabed
Yazan Z. Alabed
AAAyaz Aghayev
Ayaz Aghayev
CSChristopher Sakellis
Christopher Sakellis
AAAnnick D. Van Den Abbeele
Annick D. Van Den Abbeele
A 57-year-old man with metastatic melanoma developed colitis secondary to ipilimumab, a known immune-related adverse event (irAE). The patient then received pembrolizumab immunotherapy, an anti-programmed-death-receptor-1 (PD-1) antibody. Restaging FDG PET/CT study following 3 cycles of therapy demonstrated diffuse increased FDG uptake throughout the body of the pancreas associated with fat stranding in the peripancreatic region, suggestive of pembrolizumab-induced pancreatitis. Although the patient was clinically asymptomatic, diagnosis was biochemically confirmed with elevated amylase and lipase levels. In the era of immunotherapy, it will be critical to recognize irAEs early to allow prompt initiation of appropriate therapy and reduce the risk of long-term sequelae.

12 February 2019 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
CGChristoph Gräni
Christoph Gräni
LBLoïc Bière
Loïc Bière
CEChristian Eichhorn
Christian Eichhorn
KKKyoichi Kaneko
Kyoichi Kaneko
VAVikram Agarwal
Vikram Agarwal
RKRaymond Y. Kwong
Raymond Y. Kwong

1 April 2013 in American Journal of Roentgenology
Verified
Journal Article
Closed access
AAAyaz Aghayev
Ayaz Aghayev
AFAlessandro Furlan
Alessandro Furlan
APAmol Patil
Amol Patil
SGSerter Gumus
Serter Gumus
KJKyung Nyeo Jeon
Kyung Nyeo Jeon
KBKyongtae T. Bae
Kyongtae T. Bae
OBJECTIVE. The purpose of this article is to quantitatively assess the rate of resolution of clot burden detected on pulmonary CT angiography (CTA) in patients with acute pulmonary embolism (PE). M...